1,861
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: LUNG CANCER

Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 1574-1579 | Received 16 May 2018, Accepted 17 Jun 2018, Published online: 03 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jeffrey Crawford, Dana Herndon, Katerina Gmitter & Jared Weiss. The impact of myelosuppression on quality of life of patients treated with chemotherapy. Future Oncology 0:0, pages 1-16.
Read now

Articles from other publishers (2)

Joosje C. Baltussen, Nienke A. de Glas, Yara van Holstein, Marjan van der Elst, Stella Trompet, Anna Uit den Boogaard, Willeke van der Plas-Krijgsman, Geert Labots, Cynthia Holterhues, Jessica M. van der Bol, Lemonitsa H. Mammatas, Gerrit-Jan Liefers, Marije Slingerland, Frederiek van den Bos, Simon P. Mooijaart & Johanneke E. A. Portielje. (2023) Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients. JAMA Network Open 6:10, pages e2339116.
Crossref
Xiaowen Cao, Apar Kishor Ganti, Thomas Stinchcombe, Melisa L. Wong, James C. Ho, Chen Shen, Yingzhou Liu, Jeffery Crawford, Herbert Pang & Xiaofei Wang. (2020) Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer. Lung Cancer 141, pages 14-20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.